Breast
Progress in genetic testing, such as BRCA1 and BRCA2 mutations, has transformed preventative strategies. Targeted therapies like HER2 inhibitors and advancements in hormone therapy have significantly improved survival rates.
RAD51 testing shows promise in personalized early breast cancer treatment
Published in Clinical Cancer Research, results of a VHIO-led study underscore the potential of the RAD51 biomarker in tailoring treatment strategies in patients with early breast cancer.
New breast cancer drug given green light for NHS use
Breast Cancer Now said olaparib will be an ‘valuable alternative’ for patients with a certain type of secondary breast cancer.
Omitting Axillary Lymph Node Dissection in Early Breast Cancer
Two large trials, real-world data inform clinical decision-making
Phase III trial finds trastuzumab emtansine improves long-term survival in HER2 breast cancer
In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and improved survival compared to trastuzumab alone, according to the final results of the Phase III KATHERINE clinical trial led by researchers from the University of Pittsburgh and UPMC Hillman Cancer Center.
Medical Xpress – medical research advances and health news
Medical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and conditions, medications and more.
Mini-tumors from circulating breast cancer cells offer new treatment insights
Tumor cells circulating in the blood are the germ cells of breast cancer metastases. They are very rare and have not been propagated in the culture dish until now, which made research into therapy resistance difficult.
Grandmother, 53, Beat Stage 4 HER2-Positive Breast Cancer With Immunotherapy After Being Told To 'Enjoy The Time You Have Left'
Grandmother Tina Willits, 53, beat HER2-positive breast cancer and she's praising an immunotherapy treatment for saving her life.
Drug in clinical trials for breast cancer could also treat some blood cancers
Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
Eating egg linked to higher breast, ovary and prostate cancer risks, study finds
A recent study from Harvard University has identified a potential connection between eating eggs and the risk of developing certain types of cancer, particularly breast, ovarian, and fatal prostate cancer. The findings, published in the British Journal of Nutrition, shed light on the role egg consumption might play in the development of cancers related to sex […]
Breast cancer breakthrough: Groundbreaking daily tablet could soon be made available on NHS
The drug will be available to patients with advanced forms of the disease
Adjuvant Trastuzumab Emtansine Improves Overall Survival in HER2+ Breast Cancer
THURSDAY, Jan. 16, 2025 (HealthDay News) — For patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer, adjuvant trastuzumab
AI lasers may help detect breast cancer very early
Detecting breast cancer in its very early stages is often difficult with traditional mammograms, but a promising new technology could change that. Scottish researchers have combined artificial intelligence (AI) with advanced laser analysis to identify subtle changes in blood that may indicate the earliest signs of breast cancer. This breakthrough, published in the Journal of Biophotonics, […]
